摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

卤蜡1014 | 1335-87-1

中文名称
卤蜡1014
中文别名
多氯萘标样1014;卤蜡1014
英文名称
1,2,3,4,6,7-hexachloronaphthalene
英文别名
1,2,3,4,5,6-hexachloronaphthalene;Hexachloronaphthalene
卤蜡1014化学式
CAS
1335-87-1
化学式
C10H2Cl6
mdl
——
分子量
334.844
InChiKey
CTLMCQOGOWNFHA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    127.75°C
  • 沸点:
    421°C (rough estimate)
  • 密度:
    1.7800
  • 暴露限值:
    TLV-TWA (skin) 0.2 mg/m3 (ACGIH, MSHA, OSHA, and NIOSH); IDLH 2 mg/m3 (NIOSH).
  • 物理描述:
    Hexachloronaphthalene is a white solid with an aromatic odor. (NTP, 1992)
  • 颜色/状态:
    White solid
  • 气味:
    Aromatic odor.
  • 溶解度:
    Insoluble (NTP, 1992)
  • 蒸汽密度:
    11.6 (Air= 1 at bp of Hexachloronaphthalene)
  • 蒸汽压力:
    3.3X10-6 mm Hg @ 25 °C /Estimated/
  • 分解:
    Toxic gases and vapors (such as hydrogen chloride and carbon monoxide) may be released when /hexachloronaphthalene/ decomposes.
  • 相对蒸发率:
    Much less than 1 (Butyl Acetate= 1)
  • 保留指数:
    2505.9

计算性质

  • 辛醇/水分配系数(LogP):
    6.9
  • 重原子数:
    16
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

ADMET

代谢
/在猪体内/ 1,2,3,4,5,6-六氯未被代谢。
/In the pig/ 1,2,3,4,5,6-Hexachloronaphthalene was not metabolized.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 毒性总结
是一种有机化合物,有75种可能的同系物。商业产品通常是几种同系物的混合物,范围从薄液到硬蜡到高熔点的固体。高代的产品曾被用作冷凝器和电容器的浸渍剂,在电子和汽车应用中作为浸渍封装化合物,以及作为陶瓷组件制造的临时粘合剂,在纸张涂层和合的精密铸造中,在电镀、止焊剂、作为齿轮油和切削液的添加剂,在电缆和导线的防火和绝缘以及防潮密封剂中作为分隔器,在电池中,在折射率测试油中,在电镀中的遮蔽化合物以及在磨轮润滑剂中。 对环境的主要释放源可能是废物焚烧和将含有的物品填埋。过去,工作场所中的浓度曾达到14.5 mg/立方米,而在制造地点附近室外空气中的平为25-2900 ng/立方米。最近,监测研究发现,在半农村地区的浓度高达150 pg/立方米,在偏远地区为1-40 pg/立方米。可以通过口服、吸入和皮肤途径吸收,口服给药后会在全身分布。特别是多二苯并对位二噁烷(dioxin)样的同系物,已在普通人群的脂肪组织、肝脏、血液和母乳样本中以ng/kg脂肪的范围检测到。 在职业暴露于后,报告了严重的皮肤反应(痤疮)和肝病。在20世纪30年代至40年代,处理的工人中痤疮很常见。对电缆制造厂接触的工人进行的队列研究发现,死于肝硬化的比例过高。然而,与没有痤疮的其他工人相比,有痤疮的个体的肝硬化死亡率并没有更高。所有暴露男性的癌症死亡率略有但显著升高(标准化死亡率=1.18),但在有痤疮的亚队列中并没有更高。这个亚队列显示了食管癌和良性及未指明肿瘤的统计学上显著的超额死亡率。 接触的工人描述的症状包括眼睛刺激、疲劳、头痛、贫血、血尿、阳痿、厌食、呕吐和严重的腹痛。人类样本中发现的的多同系物/异构体模式与商业多混合物显著不同。两种主要同系物是1,2,3,5,7/1,2,5,6,7-六氯。人类组织样本和液体的分析确认了1,2,3,4,6,7-/1,2,3,5,6,7-六氯萘异构体的高保留能力。可以通过口服、吸入和皮肤途径吸收,口服给药后在全身分布。主要靶器官是肝脏和脂肪组织(其次是肾脏和肺),特别是对于更高代的同系物显示出高保留。生物积累的量随着化程度增加而增加。父母化合物和/或代谢物的消除通过粪便和尿液发生。低的毒性低于高的长期和致癌性研究尚未进行。像相关化合物一样,已被证明是细胞色素P450(CYP)依赖性微粒体酶的诱导剂。1,2,3,4,6,7-六氯萘被发现加速大鼠雄性后代精子发生。在连续5到10天的口服暴露于纯化的六氯后,牛发展出严重的角化过度。六氯在兔耳测试和无毛小鼠中显示出角化过度活性。在大鼠隔日喂食五/六氯混合物26天后,大鼠出现了中度的肝脏变化(肿胀和空泡化的肝细胞,以及散在细胞的坏死和变性)。吸入含有五/六氯的混合物在大鼠中导致轻微的组织学肝脏损伤。还发现会改变大鼠的脂质过氧化和抗氧化酶活性,以表明氧化应激的方式。至少的一些生物学和毒性反应被认为是通过细胞质Ah受体介导的,类似于2,3,7,8-四二苯并对位二噁烷(TCDD)和相关化合物的反应。 两种六氯异构体,是Halowax 1014的次要成分,单次口服剂量的Halowax 1014或由等量的1,2,3,5,6,7-六氯萘1,2,3,4,6,7-六氯萘以及第三种未识别的六氯组成的混合物。暴露一天后,动物管理Halowax 1014的脂肪组织中的多模式与技术产品相似。在
There are 75 possible congeners of chlorinated naphthalenes. Commercial products are generally mixtures of several congeners and range from thin liquids to hard waxes to high melting point solids. The higher chlorinated naphthalene products have been used as impregnates for condensers and capacitors and dipping encapsulating cmpd in electronic and automotive applications and as temporary binders in the manufacture of ceramic components, in paper coating and in precision casting of alloys, in electroplating, stop-off cmpd, as additive in gear oils and cutting cmpd, in flame proofing and insulation of electrical cable and conductors and moisture proof sealants, as separators in batteries, in refractive index testing oils, masking cmpd in electroplating and in grinding wheel lubricants. The major sources of release of chlorinated naphthalenes into the environment are likely from waste incineration and disposal of items containing chlorinated naphthalenes to landfill. In the past, chlorinated naphthalene concentration of up to 14.5 mg/cu m have been measured in the workplace, while levels of 25-2900 ng/cu m have been recorded in out door air in vicinity of manufacturing sites. More recently, monitoring studies have revealed chlorinated naphthalene concentration up to 150 pg/cu m at semi-rural sites and 1-40 pg/cu m at remote sites. Chlorinated naphthalenes can be absorbed via oral, inhalative and dermal routes, with absorption and distribution over the whole body after oral administration. Chlorinated naphthalenes, especially the dioxin like congeners, have been detected in adipose tissue, liver, blood and breast milk samples from the general population at concentration in the ng/kg lipid range. Severe skin reactions (chloracne) and liver disease have been reported after occupational exposure to chlorinated naphthalenes. Chloracne was common among workers who handling chlorinated naphthalenes in the 1930's to 1940's. A cohort study on workers exposed to chlorinated naphthalenes at a cable manufacturing plant found an excess of deaths from cirrhosis of the liver. However, individuals with chloracne did not show a higher mortality due to liver cirrhosis compared with other workers. The mortality from all cancers was slightly but significantly elevated among all exposed men (standardized mortality ratio =1.18), but was not more elevated in the subcohort with chloracne. This subcohort showed statistically significant excess mortality from cancer of the esophagus and from benign and unspecified neoplasms. Symptoms described in workers exposed to chlorinated naphthalenes included irritation of the eyes, fatigue, headache, anemia, hematuria, impotency, anorexia, vomiting and severe abdominal pain. The polychlorinated naphthalenes congener/isomer pattern found in human samples was significantly different from the commercial polychlorinated naphthalenes mixtures. Two dominating congeners were 1,2,3,5,7/1,2,5,6,7-hexachloronapthalene. Analyses of human tissue samples and fluids confirmed the high retention potency of the 1,2,3,4,6,7-/1,2,3,5,6,7-hexachloronaphthalene isomers. Chlorinated naphthalenes can be absorbed via oral, inhalative and dermal routes, with absorption and distribution over the e badministeredoy after oral admin. The main target organs are the liver and fat tissue (besides the kidney and lung) showing a high retention, especially for the higher chlorinated congeners The amount of bioaccumulation observed incr with the degree of chlorination of the chlorinated naphthalenes. Elimination of the parent compounds and/or metabolites occurs via feces and urine. Lower chlorinated naphthalenes are less toxic than the higher chlorinated naphthalenes. Long term and carcinogenicity studies with chlorinated naphthalenes have not been performed. Like related cmpd, chlorinated naphthalenes have been demonstrated to be inducers of the cytochrome p450 (CYP) dependent microsomal enzymes. 1,2,3,4,6,7-Hexachloronaphthalene has been found to accelerate the onset of spermatogenesis in male offspring of rats. Cattle developed severe hyperkeratosis during a 5 to 10 day oral exposure of purified hexachloronaphthalenes. Hexachlorinated naphthalenes showed hyperkeratoic activity in the rabbit ear test and in hairless mice. Rats fed a mixture of penta/hexachloronaphthalenes dosed on alternate days for 26 days showed moderate liver changes (swollen and vacoulated liver cells, as well as necrosis and degeneration of scattered cells.Inhalation of a mixture containing penta-/hexachloronaphthalenes resulted in slight histological liver damage in rats. Chlorinated naphthalenes were also found to change lipid peroxidation and antioxidant enzyme activities in rats in a manner indicative of oxidative stress. At least some of the biological and toxic responses of chlorinated naphthalenes are believed to be mediated via the cytosolic Ah receptor, resembling those of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related cmpd. Two hexa-isomers , which are minor components of Halowax 1014 were given single oral doses of Halowax 1014 or a mixture of hexachloronaphthalenes (consisting of equal amounts of 1,2,3,5,6,7-hexachloronaphthalene and 1,2,3,4,6,7-hexachloronaphthalene and a third unidentified hexachloronapthalene) One day after exposure the polychlorinated naphthalene patadministeredtn adipose tissue of animals admin Halowax 1014 was similar to that of the technical product. In 10 days the two hexa-isomers were dominant and after 120 days, they were the only cogeners detected, their concn beings still above 50% of the measured after day 1. In liver samples this selective retention lasted 1 day. Rats dosed with the hexachloronaphthalene mixture showed a strong similar retention of the 1,2,3,5,6,7- and 1,2,3,4,6,7-hexachloronaphthalene (the other unidentified hexachloronaphthalene could not be detected. 1,2,3,4,6,7-Hexachloronaphthalene transfer from dam to offspring has been studied in Wistar rats. Concn of this isomer were noted in the fat of female offspring. Short term exposure to higher chlorinated naphthalenes resulted in mortality, liver damage, degeneration of the kidneys etc in rats, rabbits and cattle. Inhalation of a penta/hexachloronaphthalene mixture for 143 days resulted in a slight to moderate histological liver damage in rats. All chlorinated naphthalenes tested cause skin irritations in laboratory animals. Chlorinated napthalenes appear to be of moderate to high acute toxicity to aquatic organisms. /Chlorinated naphthalenes, Halowaxes, Higher Chlorinated Naphthalenes/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 暴露途径
该物质可以通过吸入烟雾和透过皮肤被身体吸收。
The substance can be absorbed into the body by inhalation of fume and through the skin.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
毒理性
  • 暴露途径
吸入,皮肤吸收,吞食,皮肤和/或眼睛接触
inhalation, skin absorption, ingestion, skin and/or eye contact
来源:The National Institute for Occupational Safety and Health (NIOSH)
毒理性
  • 症状
痤疮样皮炎,恶心,混乱,黄疸,昏迷
Acne-form dermatitis, nausea, confusion, jaundice, coma
来源:The National Institute for Occupational Safety and Health (NIOSH)
毒理性
  • 皮肤症状
可能被吸收!发红。疼痛。
MAY BE ABSORBED! Redness. Pain.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
吸收、分配和排泄
被皮肤吸收。
Absorbed by skin.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
Sprague-Dawley大鼠(雌性;n = 12)口服单一剂量的Halowax 1014(20 mg / kg体重)或六氯混合物(0.053 mg / kg体重)(由相等量的1,2,3,5,6,7-六氯萘1,2,3,4,6,7-六氯萘和第三种未知的六氯组成)。在给药后1、10、30和120天,测量了肝脏和脂肪组织中的残留平。接触后一天,接受Halowax 1014的动物脂肪组织中的PCN模式与技术产品相似,但庚和辛的相对平较低,可能是由于这些化合物的吸收效果较差。然而,在10天内,两种六异构体(在气相色谱中共流出)占主导地位; 120天后,它们是唯一检测到的同系物,它们的浓度仍然是1天后测量的约50%。在肝脏样本中,仅在1天后就看到了这种选择性保留。用六氯混合物处理的 rats 也显示出对1,2,3,5,6,7-和1,2,3,4,6,7-六氯萘的强烈保留(其他未知的六氯无法检测)。基于两种六异构体的总浓度,计算出肝脏/脂肪组织的浓度比(基于新鲜重量)为7.3、1.1、0.8和0.63,分别在24小时和10、35和120天,基于脂质重量则为140、23、17和13。
Rats (Sprague-Dawley, female; n = 12) were given single oral doses of Halowax 1014 (20 mg/kg body weight) or of a mixture (0.053 mg/ kg body weight) of hexachloronaphthalenes (consisting of equal amounts of 1,2,3,5,6,7-hexachloronaphthalene, 1,2,3,4,6,7-hexachloronaphthalene, and a third unidentified hexachloronaphthalene). The hepatic and adipose residue levels were measured 1, 10, 30, and 120 days after dosing. One day after exposure, the PCN pattern in the adipose tissue of the animals administered Halowax 1014 was similar to that of the technical product, but the relative levels of hepta- and octachloronaphthalenes were lower, possibly due to a less effective absorption of these compounds. However, within 10 days, the two hexa-isomers (co-eluting in gas chromatography) were dominant; after 120 days, they were the only congeners detected, their concentrations being still about 50% of that measured after 1 day. In liver samples, this selective retention was seen after only 1 day. Rats dosed with the hexachloronaphthalene mixture also showed a strong, similar retention of the 1,2,3,5,6,7- and 1,2,3,4,6,7-hexachloronaphthalene (the other unidentified hexachloronaphthalene could not be detected). The concentration ratios (based on the total concentrations of the two hexa-isomers) for liver/adipose tissue were found to be remarkably high: 7.3, 1.1, 0.8, and 0.63 at 24 hr and 10, 35, and 120 days, respectively, based on the fresh weights, or 140, 23, 17, and 13, based on the lipid weights.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
1,2,3,4,6,7-六氯萘从母鼠到后代的转移在Wistar大鼠中得到研究,这些大鼠在妊娠期的第14-16天通过口服(灌胃)方式接受了1微克/千克体重的1,2,3,4,6,7-六氯萘(溶于玉米油中)的剂量。在雌性后代出生时(出生后第0天)的脂肪中,1,2,3,4,6,7-六氯萘的浓度为22.18 +/- 6.59微克/千克(相当于每只幼崽1.5-1.6纳克),在断奶时(出生后第21天)的脂肪中浓度为9.78 +/- 2.86微克/千克(相当于每只幼崽13-26纳克),而在母鼠断奶时的脂肪中浓度为5.75 +/- 2.81微克/千克;对照组中没有检测到1,2,3,4,6,7-六氯萘
The transfer of 1,2,3,4,6,7-hexachloronaphthalene from dam to offspring has been studied in Wistar rats orally (gavage) dosed with 1 ug 1,2,3,4,6,7-hexachloronaphthalene/kg body weight per day (in corn oil) on gestation days 14-16. Concentrations of 1,2,3,4,6,7-hexachloronaphthalene in fat of female offspring were 22.18 +/- 6.59 ug/kg (corresponding to 1.5-1.6 ng/pup) at birth (postnatal day 0) and 9.78 +/- 2.86 ug/kg (corresponding to 13-26 ng/pup) at weaning (postnatal day 21), and concentrations in fat of dams were 5.75 +/- 2.81 ug/kg at weaning; 1,2,3,4,6,7-hexachloronaphthalene was not detected in the control.
来源:Hazardous Substances Data Bank (HSDB)

安全信息

  • 职业暴露等级:
    C
  • 职业暴露限值:
    TWA: 0.2 mg/m3 [skin]
  • 立即威胁生命和健康浓度:
    2 mg/m3

制备方法与用途

类别:有毒物质
毒性分级:中毒
可燃性危险特性:不燃;燃烧会产生有毒化物气体
储运特性:库房需通风、低温和干燥
灭火剂:干粉、泡沫、砂土、
职业标准:TLV-TWA 0.2 毫克/立方米;STEL 0.6 毫克/立方米

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    卤蜡1014溶剂黄146 作用下, 以80%的产率得到1,2,3,5,6-Pentachloronaphthalene
    参考文献:
    名称:
    Mil'tsov; Karavan; Nikiforov, Russian Journal of Organic Chemistry, 1999, vol. 35, # 5, p. 698 - 702
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Verfahren zur reduktiven Dehalogenierung von Halogenverbindungen
    申请人:BASF Aktiengesellschaft
    公开号:EP0199066A1
    公开(公告)日:1986-10-29
    Reduktive Dehalogenierung von aliphatischen, cycloaliphatischen, aromatischen und araliphatischen Halogenverbindungen, bei denen mindestens ein Halogenatom kovalent an Kohlenstoff gebunden ist, indem man die Halogenierungen in der Gasphase im wesentlichen bei Normaldruck oder Überdruck mit Kohlenwasserstoffen an aktivem Kohlenstoff unter Bildung von Halogenwasserstoff umsetzt.
    通过在气相中基本上在常压或超压下与活性碳上的碳氢化合物反应生成卤化氢,对其中至少有一个卤原子与碳共价结合的脂族、环脂族、芳香族和脂肪族卤素化合物进行还原脱卤。
  • Verfahren zur reduktiven Dehalogenierung von organischen Halogenverbindungen
    申请人:BASF Aktiengesellschaft
    公开号:EP0290861B1
    公开(公告)日:1990-07-04
  • COMPOSITION COMPRISING GLYCEROL, PROCESS FOR OBTAINING SAME AND USE THEREOF IN THE MANUFACTURE OF DICHLOROPROPANOL
    申请人:SOLVAY SA
    公开号:EP2268596B1
    公开(公告)日:2017-05-31
  • Composition comprising glycerol, process for obtaining same and use thereof in the manufacture of dichloropropanol
    申请人:Gilbeau Patrick
    公开号:US20110028683A1
    公开(公告)日:2011-02-03
    A composition comprising glycerol and at least one cyclic oligomer of glycerol, a process for obtaining the composition, and its use in the manufacture of dichloropropanol and of derived products such as epichlorohydrin and epoxy resins.
  • US3939198A
    申请人:——
    公开号:US3939198A
    公开(公告)日:1976-02-17
查看更多